Cargando…

Changes of N6-methyladenosine modulators promote breast cancer progression

BACKGROUND: Breast cancer (BC) displays striking genetic, epigenetic and phenotypic diversity. N(6)-methyladenosine (m6A) in mRNA has emerged as a crucial epitranscriptomic modification that controls cancer self-renewal and cell fate. However, the key enzymes of m6A expression and function in human...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Lianpin, Wu, Dengying, Ning, Jinfeng, Liu, Wei, Zhang, Donghong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451293/ https://www.ncbi.nlm.nih.gov/pubmed/30953473 http://dx.doi.org/10.1186/s12885-019-5538-z

Ejemplares similares

Dual effects of N(6)-methyladenosine on cancer progression and immunotherapy
por: Li, Hui, et al.
Publicado: (2021)

Association of N(6)-methyladenine DNA with plaque progression in atherosclerosis via myocardial infarction-associated transcripts
por: Wu, Lianpin, et al.
Publicado: (2019)

RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3
por: Niu, Yi, et al.
Publicado: (2019)

Research progress of N6-methyladenosine in colorectal cancer: A review
por: Lin, Yu, et al.
Publicado: (2023)

m6A modification promotes miR-133a repression during cardiac development and hypertrophy via IGF2BP2
por: Qian, Benheng, et al.
Publicado: (2021)

N6-Methyladenosine Regulators Promote Malignant Progression of Gastric Adenocarcinoma
por: Zhao, Yibin, et al.
Publicado: (2022)

The RNA N6-Methyladenosine Methyltransferase METTL3 Promotes the Progression of Kidney Cancer via N6-Methyladenosine-Dependent Translational Enhancement of ABCD1
por: Shi, Yue, et al.
Publicado: (2021)

N6-Methyladenosine Regulators Are Involved in the Progression of and Have Clinical Impact on Breast Cancer
por: Song, Yanni, et al.
Publicado: (2021)

Effect of N6-Methyladenosine Regulators on Progression and Prognosis of Triple-Negative Breast Cancer
por: Wang, Shanshan, et al.
Publicado: (2021)

N6-methyladenosine links RNA metabolism to cancer progression
por: Dai, Dongjun, et al.
Publicado: (2018)

The potential role of RNA N6-methyladenosine in Cancer progression
por: Wang, Tianyi, et al.
Publicado: (2020)

N6-methyladenosine RNA methylation regulators contribute to the progression of prostate cancer
por: Wu, Qunying, et al.
Publicado: (2021)

FUN14 domain-containing 1 promotes breast cancer proliferation and migration by activating calcium-NFATC1-BMI1 axis
por: Wu, Lianpin, et al.
Publicado: (2019)

N(6)-methyladenosine modification of ITGA6 mRNA promotes the development and progression of bladder cancer
por: Jin, Huan, et al.
Publicado: (2019)

Reducing N6AMT1-mediated 6mA DNA modification promotes breast tumor progression via transcriptional repressing cell cycle inhibitors
por: Chen, Jiongyu, et al.
Publicado: (2022)

Research Progress of N6-Methyladenosine in the Cardiovascular System
por: Zheng, Nan, et al.
Publicado: (2020)

Long Noncoding RNA KCNMB2-AS1 Stabilized by N(6)-Methyladenosine Modification Promotes Cervical Cancer Growth Through Acting as a Competing Endogenous RNA
por: Zhang, Yao, et al.
Publicado: (2020)

N6-methyladenosine-dependent signalling in cancer progression and insights into cancer therapies
por: Tan, Fenghua, et al.
Publicado: (2021)

Functions and mechanisms of N6-methyladenosine in prostate cancer
por: Wan, Hongyuan, et al.
Publicado: (2022)

Functions of N6-methyladenosine and its role in cancer
por: He, Liuer, et al.
Publicado: (2019)

Changes in N6-Methyladenosine Modification Modulate Diabetic Cardiomyopathy by Reducing Myocardial Fibrosis and Myocyte Hypertrophy
por: Ju, Wenhao, et al.
Publicado: (2021)

Deoxycholic acid modulates the progression of gallbladder cancer through N(6)-methyladenosine-dependent microRNA maturation
por: Lin, Ruirong, et al.
Publicado: (2020)

N6‐methyladenosine‐modified HOTAIRM1 promotes vasculogenic mimicry formation in glioma
por: Wu, Zhangyi, et al.
Publicado: (2022)

Stabilization of UCA1 by N6-methyladenosine RNA methylation modification promotes colorectal cancer progression
por: He, Rong-Zhang, et al.
Publicado: (2021)

N(6)-methyladenosine contributes to cellular phenotype in a genetically-defined model of breast cancer progression
por: Fry, Nate J., et al.
Publicado: (2018)

Prognostic implications of N(6)-methyladenosine RNA regulators in breast cancer
por: Tai, Jiaojiao, et al.
Publicado: (2022)

The emerging role of RNA N6-methyladenosine methylation in breast cancer
por: Zheng, Fangchao, et al.
Publicado: (2021)

Research Progress on Long Noncoding RNAs and N6-Methyladenosine in Hepatocellular Carcinoma
por: Zhang, Wenjie, et al.
Publicado: (2022)

N(6)‐methyladenosine Steers RNA Metabolism and Regulation in Cancer
por: Dong, Shenghua, et al.
Publicado: (2021)

N(6)-methyladenosine–Mediated Upregulation of WTAPP1 Promotes WTAP Translation and Wnt Signaling to Facilitate Pancreatic Cancer Progression
por: Deng, Junge, et al.
Publicado: (2021)

Upregulated N6-Methyladenosine RNA in Peripheral Blood: Potential Diagnostic Biomarker for Breast Cancer
por: Xiao, Han, et al.
Publicado: (2021)

N(6)-Methyladenosine and Viral Infection
por: Dang, Wei, et al.
Publicado: (2019)

N(6)-Methyladenosine: A Potential Breakthrough for Human Cancer
por: Liu, Lina, et al.
Publicado: (2019)

Emerging roles of N6-methyladenosine (m(6)A) modification in breast cancer
por: Wang, Yanyan, et al.
Publicado: (2020)

Effects of N(6)-Methyladenosine Modification on Cancer Progression: Molecular Mechanisms and Cancer Therapy
por: Zhu, Yong-fu, et al.
Publicado: (2022)

N6-methyladenosine methylation in kidney injury
por: Wang, Qimeng, et al.
Publicado: (2023)

Mechanism of RNA modification N6-methyladenosine in human cancer
por: Zhou, Zijian, et al.
Publicado: (2020)

Ferroptosis Associates With Diagnosis and Prognosis by Promoting Antitumor Immune Response in Melanoma
por: Qian, Benheng, et al.
Publicado: (2022)

Understanding the roles of N(6)-methyladenosine writers, readers and erasers in breast cancer
por: Fang, Runping, et al.
Publicado: (2021)

Roles of N6‐Methyladenosine Demethylase FTO in Malignant Tumors Progression
por: Zheng, Qing-Kang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gemgdalc0kolstn6t00m9978qo